Lauren Bullaro Riker Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lauren Bullaro Riker.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lauren Bullaro Riker. Lauren Bullaro Riker is Executive Director, Accounting in Pacira Pharmaceuticals, Inc. ($PCRX) and Executive Director, Finance in Pacira Pharmaceuticals, Inc. ($PCRX) and Vice President, Finance in Pacira Pharmaceuticals, Inc. ($PCRX).
Latest Insider Trading Transactions of Lauren Bullaro Riker
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 60.96 | 6,500 | 396,240 | 6,500 | |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 59.85 | 2,003 | 119,880 | 12,731 | 14.7 K to 12.7 K (-13.59 %) |
Jun 11 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 2,600 | 0 | 14,734 | 12.1 K to 14.7 K (+21.43 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 2,000 | 21,620 | 14,300 | |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 1,520 | 16,431 | 16,300 | |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 70.01 | 2,000 | 140,020 | 13,181 | 15.2 K to 13.2 K (-13.17 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 2,000 | 21,620 | 15,181 | 13.2 K to 15.2 K (+15.17 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 73.28 | 1,520 | 111,386 | 13,181 | 14.7 K to 13.2 K (-10.34 %) |
Mar 17 2021 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 1,520 | 16,431 | 14,701 | 13.2 K to 14.7 K (+11.53 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 20,820 | |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 60.34 | 3,000 | 181,020 | 13,181 | 16.2 K to 13.2 K (-18.54 %) |
Sep 17 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 16,181 | 13.2 K to 16.2 K (+22.76 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 8,180 | 84,581 | 0 | |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 60.50 | 8,180 | 494,890 | 13,181 | 21.4 K to 13.2 K (-38.29 %) |
Aug 13 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 8,180 | 84,581 | 20,813 | 12.6 K to 20.8 K (+64.75 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 6,000 | 62,040 | 8,180 | |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 50.34 | 2,000 | 100,680 | 12,633 | 14.6 K to 12.6 K (-13.67 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.34 | 2,000 | 98,680 | 14,633 | 16.6 K to 14.6 K (-12.02 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.72 | 2,000 | 97,440 | 16,633 | 18.6 K to 16.6 K (-10.73 %) |
Jul 01 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 6,000 | 62,040 | 18,633 | 12.6 K to 18.6 K (+47.49 %) |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 47.65 | 12,000 | 571,800 | 12,000 | |
Jun 11 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 4,800 | 0 | 12,633 | 7.8 K to 12.6 K (+61.28 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.37 | 1,752 | 84,744 | 7,833 | 9.6 K to 7.8 K (-18.28 %) |
Jun 08 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.33 | 879 | 40,725 | 9,585 | 10.5 K to 9.6 K (-8.40 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 2,000 | 20,680 | 14,180 | |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 2,000 | 20,680 | 16,180 | |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 45.26 | 2,000 | 90,520 | 10,464 | 12.5 K to 10.5 K (-16.05 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 2,000 | 20,680 | 12,464 | 10.5 K to 12.5 K (+19.11 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 42.81 | 2,000 | 85,620 | 10,464 | 12.5 K to 10.5 K (-16.05 %) |
May 21 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 2,000 | 20,680 | 12,464 | 10.5 K to 12.5 K (+19.11 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 23,820 | |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.81 | 1,000 | 49,810 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.81 | 1,000 | 48,810 | 11,464 | 12.5 K to 11.5 K (-8.02 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.81 | 1,000 | 47,810 | 12,464 | 13.5 K to 12.5 K (-7.43 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 3,000 | 32,430 | 23,820 | |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 13,464 | 10.5 K to 13.5 K (+28.67 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 49.81 | 1,000 | 49,810 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 48.81 | 1,000 | 48,810 | 11,464 | 12.5 K to 11.5 K (-8.02 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.81 | 1,000 | 47,810 | 12,464 | 13.5 K to 12.5 K (-7.43 %) |
Feb 12 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 3,000 | 32,430 | 13,464 | 10.5 K to 13.5 K (+28.67 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 170 | 1,838 | 26,820 | |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 830 | 8,972 | 26,990 | |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.81 | 170 | 7,958 | 10,464 | 10.6 K to 10.5 K (-1.60 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 170 | 1,838 | 10,634 | 10.5 K to 10.6 K (+1.62 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 46.81 | 830 | 38,852 | 10,464 | 11.3 K to 10.5 K (-7.35 %) |
Feb 10 2020 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 830 | 8,972 | 11,294 | 10.5 K to 11.3 K (+7.93 %) |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 1,000 | 10,810 | 27,820 | |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 45.92 | 1,000 | 45,920 | 10,464 | 11.5 K to 10.5 K (-8.72 %) |
Dec 26 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 1,000 | 10,810 | 11,464 | 10.5 K to 11.5 K (+9.56 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.81 | 180 | 1,946 | 29,820 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 4,820 | 49,839 | 18,180 | |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.59 | 5,000 | 217,950 | 10,640 | 15.6 K to 10.6 K (-31.97 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.81 | 180 | 1,946 | 15,640 | 15.5 K to 15.6 K (+1.16 %) |
Nov 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 4,820 | 49,839 | 15,460 | 10.6 K to 15.5 K (+45.30 %) |
Jun 12 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 44.28 | 2,126 | 94,139 | 10,042 | 12.2 K to 10 K (-17.47 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 43.54 | 11,200 | 487,648 | 11,200 | |
Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 1,900 | 0 | 12,168 | 10.3 K to 12.2 K (+18.50 %) |
Jun 06 2019 | PCRX | Pacira BioSciences ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 42.91 | 967 | 41,494 | 10,268 | 11.2 K to 10.3 K (-8.61 %) |
Nov 06 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 1,000 | 10,340 | 23,000 | |
Nov 06 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 54.35 | 1,000 | 54,350 | 10,474 | 11.5 K to 10.5 K (-8.72 %) |
Nov 06 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 1,000 | 10,340 | 11,474 | 10.5 K to 11.5 K (+9.55 %) |
Sep 26 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | M | 10.34 | 1,000 | 10,340 | 24,000 | |
Sep 26 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 50.70 | 1,000 | 50,700 | 10,474 | 11.5 K to 10.5 K (-8.72 %) |
Sep 26 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Buy | M | 10.34 | 1,000 | 10,340 | 11,474 | 10.5 K to 11.5 K (+9.55 %) |
Aug 24 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 44.48 | 1,667 | 74,148 | 10,474 | 12.1 K to 10.5 K (-13.73 %) |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 38.35 | 25,000 | 958,750 | 25,000 | |
Jun 15 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 2,500 | 0 | 12,141 | 9.6 K to 12.1 K (+25.93 %) |
Jun 06 2018 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 33.02 | 801 | 26,449 | 9,641 | 10.4 K to 9.6 K (-7.67 %) |
Dec 18 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.70 | 340 | 14,858 | 10,442 | 10.8 K to 10.4 K (-3.15 %) |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 44.20 | 6,000 | 265,200 | 6,000 | |
Jun 16 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,000 | 0 | 10,063 | 7.1 K to 10.1 K (+42.47 %) |
Jun 09 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 44.37 | 1,119 | 49,650 | 7,063 | 8.2 K to 7.1 K (-13.68 %) |
Jun 07 2017 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 43.32 | 601 | 26,036 | 8,182 | 8.8 K to 8.2 K (-6.84 %) |
Dec 09 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 32.35 | 6,000 | 194,100 | 6,000 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 40.34 | 6,250 | 252,125 | 6,250 | |
Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,125 | 0 | 8,453 | 5.3 K to 8.5 K (+58.65 %) |
Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.90 | 517 | 24,765 | 5,328 | 5.8 K to 5.3 K (-8.85 %) |
Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.90 | 100 | 4,790 | 5,845 | 5.9 K to 5.8 K (-1.68 %) |
Jun 08 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Sell | S | 47.20 | 321 | 15,151 | 5,945 | 6.3 K to 5.9 K (-5.12 %) |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 79.43 | 7,500 | 595,725 | 7,500 | |
Jun 05 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,750 | 0 | 5,980 | 2.2 K to 6 K (+168.16 %) |
Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Option Exercise | M | 10.34 | 5,000 | 51,700 | 25,000 | |
Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Sell | S | 95.34 | 5,000 | 476,700 | 2,230 | 7.2 K to 2.2 K (-69.16 %) |
Mar 18 2015 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Buy | M | 10.34 | 5,000 | 51,700 | 7,230 | 2.2 K to 7.2 K (+224.22 %) |
Jun 05 2014 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Option Exercise | A | 81.00 | 15,000 | 1,215,000 | 15,000 | |
Mar 18 2013 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Option Exercise | M | 10.34 | 10,000 | 103,400 | 30,000 | |
Mar 18 2013 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Sell | S | 30.00 | 10,000 | 300,000 | 2,000 | 12 K to 2 K (-83.33 %) |
Mar 18 2013 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Buy | M | 10.34 | 10,000 | 103,400 | 12,000 | 2 K to 12 K (+500.00 %) |
Jun 07 2012 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Executive Director, ... | Option Exercise | A | 10.81 | 30,000 | 324,300 | 30,000 |
Page: 1